Electromagnetic Resonance Therapy for Autoimmune Diseases
(QSIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a new therapy called low-frequency electromagnetic resonance (LF-EMR) to determine its effectiveness for autoimmune diseases like lupus, rheumatoid arthritis, or multiple sclerosis. The goal is to see if this therapy can reduce flare-ups and lessen symptoms by improving immune cell communication. Participants will receive either the active therapy or a placebo (inactive treatment) three times a week for twelve weeks. This trial may suit those who have had an autoimmune condition for at least a year and are stable on their current medication. As a Phase 1 trial, this research focuses on understanding how the treatment works in people, offering participants the chance to be among the first to receive this new therapy.
Will I have to stop taking my current medications?
No, you will not have to stop taking your current medications. The trial requires participants to maintain their current medication schedule throughout the study.
What prior data suggests that this low-frequency electromagnetic resonance therapy is safe for autoimmune diseases?
Studies suggest that low-frequency electromagnetic resonance (LF-EMR) therapy might help reduce inflammation, benefiting people with autoimmune diseases. Research has shown that similar treatments can lessen inflammation and pain in conditions like rheumatoid arthritis.
However, as this trial is in its early stages, the treatment undergoes testing for safety. Early trials focus on how well participants tolerate the treatment and identify any possible side effects. So far, studies using similar therapies have not reported major safety issues, but ongoing research remains crucial. Participants in this trial will contribute to understanding the safety and effectiveness of LF-EMR therapy.12345Why are researchers excited about this study treatment for autoimmune diseases?
Researchers are excited about low-frequency electromagnetic resonance therapy (LF-EMR) for autoimmune diseases because it offers a non-invasive alternative to current treatments like immunosuppressive drugs and biologics, which can have significant side effects. Unlike these conventional treatments, LF-EMR uses resonant fields to promote synchronized signaling among immune cells, potentially reducing flare-ups without altering the immune system broadly. This therapy's unique mechanism targets immune cell communication directly, offering a novel approach that could complement or even replace existing therapies while minimizing side effects.
What evidence suggests that Low-Frequency Electromagnetic Resonance Therapy might be an effective treatment for autoimmune diseases?
Research has shown that low-frequency electromagnetic resonance (LF-EMR) therapy might help manage autoimmune diseases. In this trial, participants in the experimental arm will receive active LF-EMR therapy, which studies indicate can affect immune cell communication and reduce inflammation. Evidence suggests that LF-EMR could decrease the frequency and severity of flare-ups in conditions like lupus, rheumatoid arthritis, and multiple sclerosis. Specifically, previous patients have reported improved function and fewer symptoms such as pain and swelling. Overall, this treatment appears promising in controlling immune activity and providing relief for autoimmune conditions.15678
Who Is on the Research Team?
Gavin Solomon, President & CEO
Principal Investigator
Truway Health, Inc.
Are You a Good Fit for This Trial?
This trial is for people with autoimmune conditions like lupus, rheumatoid arthritis, and multiple sclerosis. Participants should be experiencing immune dysregulation but the specific eligibility criteria are not provided in the given information.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either active or sham LF-EMR sessions three times per week for twelve weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment, with blood samples collected for analysis
What Are the Treatments Tested in This Trial?
Interventions
- Low-Frequency Electromagnetic Resonance Therapy
Trial Overview
The study tests if low-frequency electromagnetic resonance (LF-EMR) can reduce autoimmune flare-ups by affecting immune cell communication. It compares active LF-EMR sessions against a sham device over twelve weeks, analyzing blood samples for cytokine levels and immune patterns using machine learning.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Placebo Group
Participants in the experimental arm will receive non-invasive low-frequency electromagnetic resonance (LF-EMR) therapy three times per week for twelve weeks. Each session uses a calibrated emitter producing resonant fields between 7-40 Hz at amplitudes below 2 microtesla. The treatment is designed to promote synchronized signaling among immune effector cells and reduce autoimmune flare frequency.
Participants in the control arm will undergo identical procedures with a deactivated (sham) LF-EMR device that emits no measurable electromagnetic field. This arm controls for placebo and procedural effects. Neither participants nor investigators will know which device is active or inactive.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Truway Health, Inc.
Lead Sponsor
Citations
Quantum-Synaptic Immunotherapy Mapping Using Low ...
It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how immune cells communicate and synchronize with ...
Extremely low frequency electromagnetic fields stimulation ...
Increasing evidence shows that extremely low frequency electromagnetic fields (ELF-EMFs) stimulation is able to exert a certain action on autoimmunity and ...
Breakthrough Clinical Trial: Quantum Immunotherapy with ...
Sponsored by Truway Health, Inc., this trial seeks to assess the effectiveness of Low-Frequency Electromagnetic Resonance Therapy (LF-EMR) and ...
The Use of Pulsed Electromagnetic Field to Modulate ...
Based on previous studies, the introduction of PEMF could provide beneficial outcomes for modulating inflammation and promoting tissue regeneration.
Positive and Negative Effects of Administering a Magnetic ...
Magnetic fields improved the functional status and reduced pain, morning stiffness and swelling in the hand.
Positive and Negative Effects of Administering a Magnetic ...
Magnetotherapy applied to patients with rheumatoid arthritis (RA) produces anti-inflammatory, analgesic and antioedema effects.
7.
ctv.veeva.com
ctv.veeva.com/study/quantum-synaptic-immunotherapy-mapping-using-low-frequency-electromagnetic-resonance-and-machine-leaQuantum-Synaptic Immunotherapy Mapping Using Low ...
It will test whether gentle, low-frequency electromagnetic resonance (LF-EMR) can influence how immune cells communicate and synchronize with ...
Immunotoxicity of radiofrequency radiation
This review aims to evaluate the RFR modulating impacts on particular immune cells contributing to various innate or adaptive immune responses.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.